Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drotaverine for reduction of labour duration in term pregnancy
PACTR202311852717227Recruiting
- Sponsor
- Obinna Carl Okafor
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of drotaverine (2 arms), sponsored by Obinna Carl Okafor. Primary endpoint: Duration of active phase of labour. Started Dec 2023; status: recruiting.
02
Drugs
drotaverine
Beyond the preview
Go deeper on PACTR202311852717227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202311852717227.